Stocks and Investing Stocks and Investing
Mon, November 6, 2023
Sun, November 5, 2023
Fri, November 3, 2023

Michael Petusky Maintained (ANIK) at Buy with Increased Target to $28 on, Nov 3rd, 2023


Published on 2024-10-28 07:21:04 - WOPRAI, Michael Petusky
  Print publication without navigation


Michael Petusky of Barrington Research, Maintained "Anika Therapeutics, Inc." (ANIK) at Buy with Increased Target from $24 to $28 on, Nov 3rd, 2023.

Michael has made no other calls on ANIK in the last 4 months.



There is 1 other peer that has a rating on ANIK. Out of the 1 peers that are also analyzing ANIK, all agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • George Sellers of "Stephens & Co." Maintained at Hold with Decreased Target to $23 on, Thursday, August 10th, 2023
Contributing Sources